Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;29(10):1281-5.
doi: 10.14670/HH-29.1281. Epub 2014 May 5.

Molecular and cellular mechanisms of heterotopic ossification

Affiliations
Review

Molecular and cellular mechanisms of heterotopic ossification

Diana M Ramirez et al. Histol Histopathol. 2014 Oct.

Abstract

Heterotopic ossification (HO) is a debilitating condition in which cartilage and bone forms in soft tissues such as muscle, tendon, and ligament causing immobility. This process is induced by inflammation associated with traumatic injury. In an extremely rare genetic disorder called fibrodysplasia ossificans progessiva (FOP), a combination of inflammation associated with minor soft tissue injuries and a hereditary genetic mutation causes massive HO that progressively worsens throughout the patients' lifetime leading to the formation of an ectopic skeleton. An activating mutation in the BMP type I receptor ALK2 has been shown to contribute to the heterotopic lesions in FOP patients, yet recent studies have shown that other events are required to stimulate HO including activation of sensory neurons, mast cell degranulation, lymphocyte infiltration, skeletal myocyte cell death, and endothelial-mesenchymal transition (EndMT). In this review, we discuss the recent evidence and mechanistic data that describe the cellular and molecular mechanisms that give rise to heterotopic bone.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
An overview of the mechanisms of heterotopic ossification. Trauma to muscle tissue stimulates sensory neurons to release Substance P, which will promote mast cell degranulation and subsequent inflammation in the area of injury. Myeloid cells and lymphocytes invade the injured tissue and promote skeletal myocyte cell death. These immune cells also release cytokines such as TGF-β2 and BMP4, which cause the vascular endothelial cells to undergo endothelial-mesenchymal transition (EndMT) to form multipotent mesenchymal stem-like cells (MSCs). Inflammatory signals and the muscle microenvironment foster these MSCs to differentiate into chondrocytes and osteoblasts to form heterotopic lesions of cartilage and bone. Resident skeletal muscle MSCs and Glast-positive progenitor cells may also contribute to the formation of the ectopic skeletal tissue.

References

    1. Bagarova J, Vonner AJ, Armstrong KA, Borgermann J, Lai CS, Deng DY, Beppu H, Alfano I, Filippakopoulos P, Morrell NW, Bullock AN, Knaus P, Mishina Y, Yu PB. Constitutively active ALK2 receptor mutants require type II receptor cooperation. Mol Cell Biol. 2013;33:2413–2424. - PMC - PubMed
    1. Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R. Mutational Analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet. 2009;17:311–318. - PMC - PubMed
    1. Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, Maidment AD, Kaplan FS, Shore EM. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res. 2012;27:1746–1756. - PMC - PubMed
    1. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br. 1982;64:76–83. - PubMed
    1. Furuya H, Ikezoe K, Wang L, Ohyagi Y, Motomura K, Fujii N, Kira J, Fukumaki Y. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H) Am J Med Genet A. 2008;146A:459–463. - PubMed

Publication types

MeSH terms